Preview

Current Pediatrics

Advanced search

THE VACCINATION AGAINST VARICELLA. THE ANSWERS TO THE PEDIATRISTS QUESTIONS

Abstract

Varicella is a disease which can be stopped by methods of specific prophylaxis. At the same time, there are no official recommendations on vaccinal prophylaxis of varicella in Russia nowadays. The article presents the answers to the most frequently asked questions of pediatrists concerning vaccination techniques, its effectiveness and safety, and vaccination in epidemic nidus. Special attention was given to the questions of vaccinal prophylaxis of varicella in immunocompromised patients.
Key words: varicella, prophylaxis, vaccination.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(3):114-119)

About the Author

V.К. Tatochenko
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


References

1. Varis T., Vesikari T. Efficacy of a high-titre live attenuated varicella vaccine in healthy young children. J. Infect. Dis. 1996; 174 (Suppl. 3): 330−334.

2. Vesikari T., Baer M., Varis T., et al. Efficacy of varicella vaccine is dependent on the virus titre. 1st World Congress of Pediatric Infectious Diseases. Acupulco, Mexico. 4−7 December 1996. Abstract: 1996.

3. Miron D., Lavi I., Kitov R. et al. Vaccine eff ectiveness and severity of varicella among previously vaccinated children during outbreaks in day care centers with low vaccination coverage. Pediatr. Infect. Dis. J. 2005; 24 (3): 233–236.

4. Kreth H.W., Lee B.W., Kosuwon P. et al. Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix). Biodrugs. 2008; 22 (6): 387–402.

5. Meurice F., De Bouver L., Vandevoorde D. et al. Immunogenicity and safety of a live attenuated varicella vaccine (Oka/SB Bio) in healthy children. J. Infect. Dis. 1996; 174 (Suppl. 3): 324−329.

6. Burgess M.A., Cossart Y.E., Wilkins T.D. et al. Varicella vaccination of health care workers. Vaccine. 1999; 17 (7-8): 765−769.

7. Ragozzino M.W., Melton L.J., Kurland L.T. et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982; 61 (5): 310–316.

8. Thomas S.L., Hall A.J. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect. Dis. 2004; 4 (1): 26–33.

9. Richards P. Shingles in one family practice. Arch. Fam. Med. 1996; 5 (1): 42–46.

10. Schmader K., George L.K., Burchett B.M. et al. Racial differences in the occurrence of herpes zoster. J. Infect. Dis. 1995; 171 (3): 701–704.

11. Donahue J.G., Choo P.W., Manson J.E., et al. The incidence of herpes zoster. Arch. Intern. Med. 1995; 155 (15): 1605–1609.

12. Mor M., Harel L., Kahan E., et al. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting – a pilot study. Vaccine. 2004; 23 (3): 325–328.

13. Bekker V., Westerlaken G.H., Scherpbier H. et al. Varicella vaccination in HIV-1-infected children after immune reconstitution. AIDS. 2006; 20 (18): 2321-2329.


Review

For citations:


Tatochenko V. THE VACCINATION AGAINST VARICELLA. THE ANSWERS TO THE PEDIATRISTS QUESTIONS. Current Pediatrics. 2009;8(3):114-119.

Views: 606


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)